Working… Menu

Dalbavancin vs Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis (AHOM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02344511
Recruitment Status : Withdrawn
First Posted : January 26, 2015
Last Update Posted : September 23, 2016
Information provided by (Responsible Party):
Durata Therapeutics Inc., an affiliate of Allergan plc ( Durata Therapeutics International BV (an Affiliate of Actavis, Inc.) )

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : October 2018
Estimated Study Completion Date : April 2019